A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints. (Q30619309)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pancreatic cancer

1 reference

based on heuristic

inferred from title

Michael Wakelam

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

D R Ferry

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Deakin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Baddeley

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Daryanani

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Bramhall

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D A Anderson

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Doran

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Pemberton

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A M Young

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J Buckels

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D J Kerr

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1165-1170

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer of the pancreas. 50 years of surgery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative and adjuvant regional chemotherapy in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of gemcitabine in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel anti-tumour activity of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4- benzoquinone (CV-6504) against established murine adenocarcinomas (MAC).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Signaling inhibitors in the clinic: new agents and new challenges

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008303715515

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008303715515

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11061613%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30619309&oldid=1967240295"